Alpha Tau Medical Ltd. (NASDAQ:DRTSW – Get Free Report) shares were up 14.3% on Thursday . The company traded as high as $0.24 and last traded at $0.24. Approximately 1,300 shares changed hands during trading, a decline of 89% from the average daily volume of 12,108 shares. The stock had previously closed at $0.21.
Alpha Tau Medical Price Performance
The stock’s 50-day moving average price is $0.22 and its 200-day moving average price is $0.21.
About Alpha Tau Medical
Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. The company's Alpha-DaRT technology is in clinical trials for various forms comprising skin, oral, pancreatic, prostate, lung, liver, and breast cancers; preclinical or pending clinical studies for brain and other cancers; and preclinical studies for hepatic cell carcinoma, glioblastoma multiforme, lung cancer, and others.
See Also
- Five stocks we like better than Alpha Tau Medical
- The Role Economic Reports Play in a Successful Investment Strategy
- 3 Legacy Tech Companies Reemerging as AI Leaders
- Best Aerospace Stocks Investing
- Analysts’ Favorite Cybersecurity Stocks: 3 Top Picks
- Business Services Stocks Investing
- Analysts Are Bullish: 3 Tech Giants With Upgraded Price Targets
Receive News & Ratings for Alpha Tau Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alpha Tau Medical and related companies with MarketBeat.com's FREE daily email newsletter.
